79.96
0.55 (0.69%)
| Penutupan Terdahulu | 79.41 |
| Buka | 79.33 |
| Jumlah Dagangan | 322,076 |
| Purata Dagangan (3B) | 559,403 |
| Modal Pasaran | 4,015,902,976 |
| Harga / Pendapatan (P/E TTM) | 33.18 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.88 |
| Harga / Jualan (P/S) | 2.90 |
| Harga / Buku (P/B) | 4.38 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Feb 2025 |
| Margin Keuntungan | 9.10% |
| Margin Operasi (TTM) | 16.44% |
| EPS Cair (TTM) | 2.41 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 8.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 35.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 149.62% |
| Nisbah Semasa (MRQ) | 3.49 |
| Aliran Tunai Operasi (OCF TTM) | 84.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 85.98 M |
| Pulangan Atas Aset (ROA TTM) | 5.88% |
| Pulangan Atas Ekuiti (ROE TTM) | 13.97% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Haemonetics Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -4.0 |
| Purata | -0.50 |
|
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.89% |
| % Dimiliki oleh Institusi | 113.64% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Neuberger Berman Group Llc | 30 Sep 2024 | 4,027,103 |
| Thrivent Financial For Lutherans | 30 Sep 2024 | 1,100,183 |
| Schroder Investment Management Group | 30 Sep 2024 | 937,289 |
| Westfield Capital Management Co Lp | 30 Sep 2024 | 823,663 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 120.00 (Raymond James, 50.08%) | Beli |
| Median | 114.00 (42.57%) | |
| Rendah | 108.00 (Barrington Research, 35.07%) | Beli |
| Purata | 114.00 (42.57%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 84.35 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 06 Dec 2024 | 116.00 (45.07%) | Beli | 81.19 |
| Barrington Research | 04 Dec 2024 | 108.00 (35.07%) | Beli | 83.51 |
| 08 Nov 2024 | 108.00 (35.07%) | Beli | 87.42 | |
| Needham | 03 Dec 2024 | 112.00 (40.07%) | Beli | 85.26 |
| 15 Nov 2024 | 112.00 (40.07%) | Beli | 89.22 | |
| Raymond James | 08 Nov 2024 | 120.00 (50.08%) | Beli | 87.42 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 Jan 2025 | Pengumuman | Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A |
| 08 Jan 2025 | Pengumuman | Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 |
| 06 Jan 2025 | Pengumuman | Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference |
| 03 Dec 2024 | Pengumuman | Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A |
| 07 Nov 2024 | Pengumuman | Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |